NXL · Forms 3, 4, 5
Insider trades at Nexalin Technology, Inc.
No open-market insider buys or sells at Nexalin Technology, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Nexalin Technology, Inc. (NXL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Nexalin Technology, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mark White | CEO | Options or other derivatives | Form 4 | ||||
| Fleet Justin Van | CFO | Options or other derivatives | Form 4 | ||||
| David Owens | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Carolyn Hamby Shelton | Sr. VP - Quality - Regulatory | Options or other derivatives | Form 4 | ||||
| Ben Hu | Director | Options or other derivatives | Form 4 | ||||
| Alan Kazden | Director | Options or other derivatives | Form 4 | ||||
| Leonard Osser | 10% owner | Award | 83,333 | Form 4 | |||
| David Owens | Chief Medical Officer | Award | 36,459 | Form 4 | |||
| Ben Hu | Director | Award | 36,459 | Form 4 | |||
| Alan Kazden | Director | Award | 36,459 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.